News

Autolus Therapeutics plc filed a Current Report on Form 8-K on November 10, 2026, announcing its financial results for the quarter ended September 30, 2026, and furnishing an updated corporate presentation used in connection with a same-day conference call.

Passage Bio, Inc. filed its quarterly report on Form 10-Q with the SEC on November 10, 2026, covering the period ended September 30, 2026, and reporting significant changes to its balance sheet compared to December 31, 2025.

State Street Corporation filed a Schedule 13G with the SEC on November 10, 2026, disclosing a beneficial ownership position in the common stock of Eastern Bankshares Inc as of September 30, 2026.

Cullinan Therapeutics, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 10, 2026, disclosing operational and financial information for the third quarter.

908 Devices Inc. filed its quarterly report on Form 10-Q with the SEC on November 10, 2026, covering the fiscal quarter ended September 30, 2026, and reporting total assets of $199,358 thousand alongside a significantly expanded share count.

State Street Corporation filed a Schedule 13G with the SEC on November 10, 2026, disclosing beneficial ownership of 9,040,863 shares of EchoStar Corp common stock, representing 5.7% of the class, as of September 30, 2026.

State Street Corporation filed a Schedule 13G with the SEC on November 10, 2026, disclosing beneficial ownership of approximately 5% of Expedia Group Inc's common stock as of September 30, 2026.